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The identification of genes and deduced pathways from the
mature human oocyte can help us better understand oogenesis,
folliculogenesis, fertilization, and embryonic development. Human
metaphase II oocytes were used within minutes after removal from
the ovary, and its transcriptome was compared with a reference
sample consisting of a mixture of total RNA from 10 different
normal human tissues not including the ovary. RNA amplification
was performed by using a unique protocol. Affymetrix Human
Genome U133 Plus 2.0 GeneChip arrays were used for hybridizations. Compared with reference samples, there were 5,331 transcripts significantly up-regulated and 7,074 transcripts significantly
down-regulated in the oocyte. Of the oocyte up-regulated probe
sets, 1,430 have unknown function. A core group of 66 transcripts
was identified by intersecting significantly up-regulated genes of
the human oocyte with those from the mouse oocyte and from
human and mouse embryonic stem cells. GeneChip array results
were validated using RT-PCR in a selected set of oocyte-specific
genes. Within the up-regulated probe sets, the top overrepresented categories were related to RNA and protein metabolism,
followed by DNA metabolism and chromatin modification. This
report provides a comprehensive expression baseline of genes
expressed in in vivo matured human oocytes. Further understanding of the biological role of these genes may expand our knowledge on meiotic cell cycle, fertilization, chromatin remodeling,
lineage commitment, pluripotency, tissue regeneration, and
morphogenesis.
genechip 兩 microarray 兩 RT-PCR 兩 pluripotency 兩 RNA amplification

T

he mammalian oocyte is responsible for a number of extraordinary biological processes. It has the ability to haploidize its DNA, to reprogram sperm chromatin into a functional
pronucleus, to drive early embryonic development, and to give
rise to pluripotent embryonic stem cells (ESCs). Identifying the
genes in the oocyte that are essential for oogenesis, folliculogenesis, fertilization, and early embryonic development will
provide a valuable genomic resource in reproductive and developmental biology. However, the oocyte transcriptome and its
functional significance in the human are relatively unknown
because of ethical and technical limitations.
Although extensive genomic studies of oocytes and preimplantation embryos have been conducted in mouse oocytes
(1–6), in human the accessibility of mature oocytes i.e., metaphase II (MII) oocytes, has been a major barrier to studying
oocyte genomics using microarrays. Attempts have been made to
address this problem by using candidate gene approaches employing RT-PCR and differential display (7–22). In addition,
serial analysis of gene expression (SAGE) and cDNA libraries
was generated from human oocytes, and SAGE tags and expressed sequence tags were sequenced for rapid gene discovery
and expression profiling in the oocytes (see reviews in refs. 23
and 24). However, these molecular approaches resulted in a
small number of genes analyzed in each sample. Recently, four
reports described initial transcriptome analyses of human oocytes using microarrays (25–28). Although they provided valuable information, these studies did not present a comprehensive
www.pnas.org兾cgi兾doi兾10.1073兾pnas.0603227103

picture of the human oocyte transcriptome because of a number
of biological and technical constraints. Among the biological
impediments are the use of discarded human oocytes that have
failed to fertilize (25, 28), limited coverage of the microarrays
(25, 27), in some cases lack of sufficient biological replications
(26, 28), and technical issues (27). Among the technical shortcomings, the most important is the use of a potentially unfaithful
RNA amplification protocol. Li et al. (27) seem to have synthesized the first-strand cDNA using only a simple oligo(dT) primer,
which makes target amplification unfeasible (27); however, the
actual procedure used for RNA amplification is unclear. Although we recognize this issue could have been a mistake on
their described-published protocol, the actual procedure used
for RNA amplification remains elusive. Our study addresses
these concerns. First, we used young oocytes, as opposed to aged
and fertilized ones, which could have quite significantly different
expression profiles; second, we used the most comprehensive
human microarray platform; and third we took advantage of
publicly available gene expression databases to interpret our own
data in a more meaningful way. Thus, the present study was
conducted to identify the gene transcripts present in young,
untreated MII oocytes within minutes after isolation from the
ovary in three independent replicates and to compare these
genes with a reference RNA (a mixture of total RNA from 10
different normal human tissues not including the ovary) by using
Affymetrix GeneChip technology. To achieve this goal, a protocol that combined template-switching PCR and T7-based
amplification methods was developed for the analysis of gene
expression in samples of small quantity. We amplified RNA from
the oocyte and reference samples. Results were later compared
with available transcriptome databases of mouse oocytes, and
human ESCs (hESCs) and mouse ESCs (mESCs). Here, we
report the transcript profile of in vivo matured human MII
oocytes using the most recent Affymetrix human GeneChip
array, interrogating ⬎47,000 transcripts including 38,500 well
characterized human genes.
Results and Discussion
Validation of Amplification Fidelity (Amplified vs. Nonamplified RNA).

A critical step in the analysis of gene expression on small samples
is the faithful amplification of mRNA molecules present in the
sample. We have designed a PCR-based amplification system
using the combination of SMART II A oligonucleotide (Clontech, Mountain View, CA) and T7-Oligo(dT) promoter primers
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Fig. 1. Summary of CRL RNA amplification protocol. (A) Flow Chart of the CRL amplification protocol. (B) Representative plot of gene intensities comparing
the CRL and Ambion amplification methods using 20 ng and 1 g of total RNA, respectively.

(CRL RNA amplification protocol) (Fig. 1A). We isolated total
RNA from a human cell line and 20, 3, and 1.5 ng input total
RNA was amplified using the CRL amplification protocol. For
each experiment, 15 g of fragmented amplified RNA (aRNA)
was hybridized to a single Affymetrix Human Genome U133
Plus 2.0 array. Nonamplified RNA from the same original
sample (1 g) was run in parallel by using the MessageAmp II
aRNA Kit (Ambion, Austin, TX). Gene expression results from
both amplified vs. nonamplified RNA samples were compared,
and the correlation coefficients were found to be 0.94 (Fig. 1B),
0.93, and 0.91 for 20 ng, 3 ng, and 1.5 ng of total input RNA,
respectively. The CRL Amplification protocol was repeated two
times with 20 ng of initial total RNA from the same cell type, and
the correlation between the two experiments was 0.99. These
results show that our RNA amplification strategy faithfully and
consistently amplifies small amounts of RNA to quantities
required to perform microarray experiments. The CRL amplification protocol provides a practical approach to facilitate the
analysis of gene expression in samples of small quantity while
maintaining the relative gene expression profile throughout
reactions.
Validation of Microarray Data. A selected list of genes was used to
validate the microarray results by RT-PCR (Fig. 2). These genes

Fig. 2. RT–PCR verification of the GeneChip array result. Loading orders of
the gel were as following: M, 100 bp molecular weight standards with sizes as
indicated on the left margin; OCT4, POU domain, class 5, transcription factor
1; STELLA, DPPA3, developmental pluripotency-associated 3; ESG1, embryonal
stem cell-specific gene 1; VASA, DEAD box RNA helicase; GDF9, growth
differentiation factor 9; ZP1, zona pellucida glycoprotein 1; H1FOO, H1 histone family, member O, oocyte-specific; CDH3, cadherin 3, type 1, P-cadherin
(placental); TUBB4Q, ␤-tubulin; ACTB, ␤-actin; and negative control with no
DNA template.
14028 兩 www.pnas.org兾cgi兾doi兾10.1073兾pnas.0603227103

were found to be present in the oocyte sample and absent in the
reference RNA.
Differentially Up-Regulated Genes in the Human Oocyte. We gener-

ated a database of the human oocyte transcriptome by comparing the transcripts in the oocyte with the reference samples,
which contain mRNA from several somatic tissues. A complete
list of up- and down-regulated genes and functional, comparative, and correlation analyses are available (see Data Sets 1 and
2 at www.canr.msu.edu兾dept兾ans兾community兾people兾
cibelli㛭jose.html). Although the oocytes were thoroughly denuded manually from their surrounding cells, we were concerned
over the risk for potential contamination of RNA belonging to
cumulus cells. We then specifically checked for the levels of
expression of cumulus cell-specific genes, such as GREM1,
PTGS2 and PTX3, and found them absent or down-regulated in
the oocyte RNA samples.
Compared with reference samples, there were 5,331 transcripts significantly up-regulated and 7,074 transcripts significantly down-regulated in the oocyte. Genes up-regulated in
oocyte samples included most of the well-known germ cellspecific genes, such as FIGLA, STELLA, VASA, DAZL, GDF9,
ZP1, ZP2, MOS, OCT4, NPM2, and H1FOO. Using Ingenuity
Software Knowledge Base (Redwood City, CA), we confirmed
the presence of pathways previously described in the mouse, in
particular the TGF-␤ pathway (Fig. 3).
The number of genes expressed in young MII human oocytes was
7,560 in our study (based on Unigene build 189; see Data Set 3,
which is available at www.canr.msu.edu兾dept兾ans兾community兾
people兾cibelli㛭jose.html) whereas the only other study employing
the same microarray (28) reported the gene number as 5,633 in aged
human oocytes. As the complete list of genes is not available, a
direct comparison of these data sets is not feasible. Although there
is overlap between the two data sets, the difference in the number
of genes detected could be because the oocytes assayed in the two
studies were not equivalent to each other (young MII oocytes vs.
unfertilized and aged oocytes) or the effect of different RNA
amplification protocols used.
Functional Annotation of Genes Overexpressed in the Human Oocyte.

To examine the biological processes performed by the oocyte, we
implemented Expression Analysis Systematic Explorer (EASE)
(29), contrasting the genes overexpressed in the oocyte with all
Kocabas et al.
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Fig. 3.

TGF-␤ signaling pathway. Genes shown in red are differentially up-regulated in human oocytes.

of the genes present in the Affymetrix chip (Table 1, which is
published as supporting information on the PNAS web site). One
of the top overrepresented categories found in oocytes was
related to RNA metabolism. This finding is in agreement with
the fact that oocytes store RNA to support the events of
fertilization and early embryonic development until the embryonic genome is activated (30, 31). DNA metabolism and chromatin modification were also overrepresented categories, in
agreement with the need of the oocyte to remodel the sperm
chromatin upon fertilization. Detection of gametogenesis and
reproduction as overrepresented categories further suggests the
accuracy of this transcriptional profiling. An important category
highly represented in the oocyte was related to nucleic acid
metabolism and regulation of transcription. Although transcriptionally silent at the MII stage, the oocyte is very active in
transcription and translation throughout its growth phase and
must be prepared to initiate transcription during embryonic
genome activation at the four- to eight-cell stage in human (32).
Many of the genes in this category represent Zinc-finger proteins
that are not yet fully characterized, providing an opportunity to
discover new transcriptional regulatory networks that operate
during embryonic genome activation.
Chromatin remodeling genes are also represented in the
human oocyte. Genes in this category included the following:
DNA methyltransferases (DNMT1, DNMT3A and DNMT3B),
histone acetyltransferases (NCOA1 and -3, SRCAP, GCN5L2,
and TADA2L), histone deacetylases (HDAC3, HDAC9, and
SIRT7), methyl-CpG-binding proteins (MBD2 and MBD4),
Kocabas et al.

histone methyltransferases (EHMT1 and SET8), AT Pdependent remodeling complexes (SMARCA1, SMARCA5,
SMARCAD1, SMARCC2, and SMARCD1), and other chromatin-modifying genes (ESR1, NCOA6, HMGB3, HMGN1, and
HMGA1). These Gene Ontology results not only validate our
transcriptome analysis when compared with candidate gene
analysis already reported in other species but more importantly,
shed new light into a large number of biological processes that
take place in the human oocyte.
Intersection Between Human Oocyte and Mouse Oocyte Transcriptome. Mouse has been the best model for genetic studies, and

several groups have already reported the transcriptome analysis
of mouse oocytes (4, 6). In an effort to find differences and
similarities between the human and mouse oocyte, we compared
our human oocyte transcriptome results with that of mouse
oocyte transcriptome derived from data of Su et al. (33). We
intersected differentially up-regulated genes in the human and
the mouse oocyte transcriptome and found a set of 1,587 genes
to be in common, indicating genes of conserved function in
mammalian oocytes (Fig. 4A and Data Set 4, which is available
at www.canr.msu.edu兾dept兾ans兾community兾people兾cibelli㛭jose.
html). The functional characterization of 15 of the top 100
intersected genes that have their functions described in mouse
oocytes is summarized in Table 2, which is published as supporting information on the PNAS web site. Many of these genes
relate to oocyte maturation, from the first meiotic division to
MII arrest, encompassing various controls of cell cycle checkPNAS 兩 September 19, 2006 兩 vol. 103 兩 no. 38 兩 14029

Fig. 4. Venn diagrams showing the intersection between differentially up-regulated genes in the human (HU OC) and mouse oocytes (MO OC) (1,587 transcripts were
found to be in common in both species) (A); HU OC and hESCs (388 transcripts were found to be common in both cell types) (B); MO OC and mESCs (591 transcripts were
found to be common in both cell types) (C); and HU OC兾hESC and MO OC兾mESC (78 transcripts were found to be common in all four cell types (D).

points and cellular machinery for DNA segregation and cell
division. It was surprising to find at the intersection of these data
sets the up-regulation of the estrogen receptor (ER) signaling
pathway (Fig. 5, which is published as supporting information on
the PNAS web site). Genes significantly up-regulated in this
pathway were CTBP2, ESR1, GTF2H1, GTF2H2, MAP2K1,
NCOA1, NCOA3, PCQAP, PHB2, POLR2C, POLR2J, RBM9,
TAF3, TAF4 and 4B, TAF5, TAF6, TAF12, and TBP. Recent
studies in knockout models for aromatase have shown that
estrogen is not required for the generation of preimplantation
embryos (34); our study, however, in agreement with previous
reports (35, 36) suggests that some genes associated with the ER
pathways are indeed transcribed in the oocyte, perhaps in
response to hormonal stimulation during folliculogenesis and
oocyte maturation. It remains to be determined whether the ER
pathway has a role during preimplantation development in
human embryos. Considering the high degree of similarity in
early embryonic development between mouse and human, these
1,587 common genes deserve particular attention and must be
considered for future candidate gene-approach studies related to
fertility disorders, developmental defects, and assisted reproductive technologies. Furthermore, with the inherent ethical and
technical difficulties of studying human oogenesis in the laboratory, the mouse model will continue to provide a platform for
the functional characterization of other highly conserved genes
that may bear significance in understanding human germ cell
formation and maturation.
Intersection Between Oocytes and ESC Transcriptomes. The oocyte is
derived from germ cell precursors believed to have segregated
from pluripotent precursors before somatic tissue differentiation
(37). Primordial germ cells (PGCs) undergo mitotic proliferation
followed by meiosis. By the time the oocyte reaches the MII
stage, it is already a highly specialized cell capable of remodeling
the sperm nucleus and restoring totipotency to the diploid
zygote. In addition, somatic cell nuclear transfer (SCNT) into
enucleated oocytes has shown that, when challenged with a
14030 兩 www.pnas.org兾cgi兾doi兾10.1073兾pnas.0603227103

somatic nucleus, the oocyte cytosol will attempt to completely
erase the somatic epigenetic phenotype and transform the
nucleus to a totipotent state. Although failures in this epigenetic
reprogramming have been reported elsewhere, there are reported cases in which animals produced by SCNT have developed normally (38). Reinforcing the notion that, when SCNT is
performed under ideal circumstances (yet to be described), the
oocyte cytosol can turn a somatic nucleus into a totipotent one.
Recent somatic cell–ESC fusion experiments suggest that ESCs
retain similar as yet undefined components that can initiate the
reprogramming of introduced somatic nucleus to confer pluripotency to the somatic nuclei (as measured by phenotypic and by
transcriptional analyses). In this respect, the cytoplasmic environment of both ESCs and oocytes shares the capacity to
reprogram a somatic nucleus (39–41). Furthermore, recent work
suggests that mESCs can give rise to PGCs that can differentiate
into cells similar to oocytes and sperm in a period significantly
shorter when compared with in vivo gametogenesis (42, 43).
Taken together, this evidence indicates that there is a common
set of genes between oocytes and ESCs responsible for reprogramming somatic cells. To identify these genes, differentially
up-regulated transcripts in the oocyte were compared and
intersected with recently published data for genes that are
expressed preferentially in ESCs (44). Our analysis of the Sato
et al. (44) data revealed 1,626 hESC differentially up-regulated
genes. When these hESC genes were intersected with our human
differentially up-regulated oocyte transcripts, we found an overlap of 388 transcripts (Fig. 4B and Data Set 5, which is available
at www.canr.msu.edu兾dept兾ans兾community兾people兾cibelli㛭
jose.html). Our final intersection was drawn between these 388
human transcripts and a list of 591 genes common to mouse
oocyte and mESCs (Fig. 4C and Data Set 6, which is available
at www.canr.msu.edu兾dept兾ans兾community兾people兾cibelli㛭jose.
html). A final list of 66 unique genes (78 transcripts) common
amongst mouse oocyte, mESCs, human oocyte, and hESCs was
obtained; five of these genes have unknown functions (Fig. 4D;
Table 3, which is published as supporting information on the
Kocabas et al.

Conclusions
Our report provides a comprehensive expression baseline of
gene transcripts present in in vivo matured human MII oocytes.
Using the most recent Affymetrix Human GeneChip, we have
identified 5,331 transcripts highly expressed in human oocytes,
including well known genes such as FIGLA, STELLA, VASA,
DAZL, GDF9, ZP1, ZP2, MOS, OCT4, NPM2, NALP5兾
MATER, ZAR1, and H1FOO. More importantly, 1,430 of these
up-regulated genes have unknown functions, arguing for the
need for further studies aimed to elucidate the functional role of
these genes in the human oocyte.
We have also identified a significant number of genes common
between hESCs and MII oocytes. Such genes may provide the
missing link between ESCs and MII oocytes and may serve as
genetic resources to identify ESCs that have full potential for
differentiation into an oocyte.
As in the case of many microarray studies, profiling of the
genes in the tissues of interest is the first step of a comprehensive
experimental approach toward dissecting biological processes
and their players at the molecular level. The data sets created in
our experiments (which are available at www.canr.msu.edu兾
dept兾ans兾community兾people兾cibelli㛭jose.html) will provide
some of the means to address hypothesis-driven questions regarding unique functions of the oocyte.
Further understanding of the biological role of these genes
may expand our knowledge of the meiotic cell cycle, fertilization,
chromatin remodeling, lineage commitment, pluripotency, tissue
regeneration, and morphogenesis. The practical implications of
compiling gene expression information on human gametes and
embryos would be enormous by bolstering efforts to solve
problems from infertility to degenerative diseases.
Materials and Methods
Oocyte Collection, Total RNA Extraction, and Reference RNA. Human

oocytes were obtained from three patients undergoing an assisted reproductive treatment (ART) at the Unit of Reproductive Medicine of Clinica Las Condes, Santiago, Chile. It is
important to emphasize that the routine in vitro fertilization
protocol at Clinica Las Condes calls for fertilizing only those
oocytes that will be transferred into the uterus of the patient.
Therefore, there is always a surplus of oocytes. We then had the
opportunity to use specific criteria to select donors as follows: (i)
⬍35 years old, (ii) reproductively healthy with regular ovulatory
cycles, (iii) male factor as the only cause of infertility, and (iv)
considerable number of developing follicles that assured spared
oocytes. The experimental protocol was reviewed and approved
by a local independent Ethics Review Board. All donors signed
informed consent. At the time this manuscript was submitted, all
three donors had already conceived; two of them got pregnant
during the ART cycle in which our samples were collected, and
the third one got pregnant after a spontaneous cycle with
artificial insemination using donated sperm. Ovarian stimulation, oocyte retrieval, and cell lysis were performed as described
in Supporting Materials and Methods, which is published as
supporting information on the PNAS web site.
Three groups of 10 oocytes each were used. Total RNA was
isolated following the guanidium thiocyanate method (45) by
Kocabas et al.

using the PicoPure RNA isolation kit (Arcturus, Sunnyvale, CA)
following the manufacturer’s instructions. However, only 6.5 l
of elution buffer (Arcturus) was used, and the elution was
repeated at least three times by using the first eluate. All RNA
samples within the purification column were treated with the
RNase-Free DNase (Qiagen, Valencia, CA). Extracted RNA
was stored at ⫺80°C until used as template for cDNA synthesis.
The quality and quantity of extracted total RNA from 8 matured
oocytes (independent from the 30 oocytes used in this study) was
evaluated on the Agilent 2100 bioanalyzer (Agilent Technologies, Palo Alto, CA). Each mature oocyte was found to have
⬇330 pg of total RNA when the Arcturus RNA isolation kit was
used. The quality of RNA was intact as shown in Fig. 6, which
is published as supporting information on the PNAS web site.
Reference RNA (100 g) was prepared by mixing 10 g of total
RNA from each of 10 different normal human tissues, including
skeletal muscle, kidney, lung, colon, liver, spleen, breast, brain,
heart, and stomach (Ambion).
First-Strand cDNA Synthesis and cDNA Purification. The following
reagents were added to each 0.5 ml of RNase-free tube: 5 l total
RNA (i.e., 3 ng for the reference and ⬇3 ng for the oocyte
samples) and 300 ng of an anchored T7-Oligo(dT)24V promoter
primer (Ambion). The reaction tubes were incubated in a
preheated PCR machine at 70°C for 2 min and transferred to ice.
After denaturation, the following reagents were added to each
reaction tube: 1.4 l of SMART II A oligonucleotide (5⬘A AGCAGTGGTATCA ACGCAGAGTACGCGrGrGr-3⬘)
(Clontech), 4 l of 5⫻ first-strand buffer, 2 l of 20 mM DTT,
0.6 l of 5 mg兾ml T4 Gene 32 Protein (Roche, Indianapolis, IN),
2 l of 10 mM dNTPs, 20 units of RNase inhibitor (Ambion), and
1 l of PowerScript Reverse Transcriptase (Clontech). The final
first-strand reaction volume was 20 l for all experiments. After
gently mixing, reaction tubes were incubated at 42°C for 60 min
in a hot-lid thermal cycler. The reaction was terminated by
heating at 70°C for 15 min and purified by NucleoSpin Extraction
Kit (Clontech) following the manufacturer’s instructions.
Double-Stranded cDNA Synthesis by Long-Distance PCR and cDNA
Purification. PCR Advantage 2 mix (9 l) was prepared as follows:

5 l of 10⫻ PCR Advantage buffer (Clontech), 1 l of 10 mM
dNTPs, 100 ng of 5⬘ SMART upper primer (5⬘-AAGCAGTGGTATCAACGCAGAGTA-3⬘), 100 ng of 3⬘ SMART lower primer
(5⬘-CGGTAATACGACTCACTATAGGGAGAA-3⬘), and 1 l
of Polymerase Mix Advantage 2 (Clontech). This mix was added to
41 l of the first-strand cDNA synthesis reaction product, and
thermal cycling was carried out in the following conditions: 95°C for
1 min, followed by 15 cycles, each consisting of denaturation at 94°C
for 30 s, annealing at 62°C for 30 s, and extension at 68°C for 10 min.
The cDNA was purified by the NucleoSpin Extraction Kit
(Clontech).
For in vitro transcription, biotin-labeled aRNA purification
and aRNA fragmentation, hybridization, washing, staining and
imaging, and RT-PCR analysis, see Supporting Materials and
Methods.

Microarray Analysis. Transcriptional profile of each sample was

probed by using Affymetrix Human Genome U133 Plus 2.0
GeneChips. The raw data obtained after scanning the arrays
were analyzed by dChip (46). A smoothing spline normalization
method was applied before obtaining model-based gene expression indices, also known as signal values. There were no outliers
identified by dChip so all samples were carried on for subsequent
analysis.
When comparing two groups of samples to identify genes
enriched in a given group, we used the lower confidence bound
(LCB) of the fold change (FC) between the two groups as the
cut-off criteria. If 90% LCB of FC between the two groups was
PNAS 兩 September 19, 2006 兩 vol. 103 兩 no. 38 兩 14031

DEVELOPMENTAL
BIOLOGY

PNAS web site; and Data Set 7, which is available at www.canr.msu.edu兾dept兾ans兾community兾people兾cibelli㛭jose.html).
Among these 66 unique genes, there is a high abundance of
chromatin and DNA modifying genes, suggesting that the genomes of both the ESCs and oocytes are maintained in a
responsive or primitive-naive state, potentially primed for the
activation of a whole repertoire of genes leading the generation
of all tissue lineages. Whether any of these genes are involved
in the ability to reprogram somatic nuclei should be further
explored.

⬎2, the corresponding gene was considered to be differentially
expressed (DE). LCB is a stringent estimate of the FC and has
been shown to be the better ranking statistic (46). Recently,
dChip’s LCB method for assessing DE genes has been shown to
be superior to other commonly used approaches, such as MAS
5.0 and Robust Multiarray Average-based methods (47, 48).
Pathways analysis was performed by using Ingenuity Software
Knowledge Base (Redwood City, CA), which is a manually
created database of previously published findings on mammalian
biology from the public literature. We used the network analysis,
using the knowledge base to identify interactions of input genes
within the context of known biological pathways.
Gene Ontology was performed by using the EASE software
package (http:兾兾david.niaid.nih.gov兾david兾ease.htm). Given a
list of genes, EASE forms subgroups based on the functional
categories assigned to each gene. EASE assigns a significance
level (EASE score) to the functional category based on the
probability of seeing the number of subgroup genes within a
category given the frequency of genes from that category
appearing on the microarray (29).

pression value in oocyte samples that are 2-fold higher than the
baseline.
Human ESC data were derived from the work of Sato et al.
(44), who profiled human stem cells and their differentiated
counterparts using Affymetrix HG-U133A representing
⬇22,000 transcripts.
We analyzed the raw data using dChip and identified 1,626
hESC genes by selecting transcripts significantly up-regulated in
human stem cells compared with their differentiated counterparts (see Data Set 9, which is available at www.canr.msu.edu兾
dept兾ans兾community兾people兾cibelli㛭jose.html).
Finally, for mESCs, we used a list of 1,687 differentially upregulated mESC genes published by Fortunel et al. (49), which were
identified by comparing mESCs to differentiated cells by using
Affymetrix MG-U74Av2 chips representing ⬇12,000 transcripts
(see Data Set 10, which is available at www.canr.msu.edu兾dept兾
ans兾community兾people兾cibelli㛭jose.html). We used Affymetrix’s
NetAffx tool (https:兾兾www.affymetrix.com兾analysis兾netaffx兾
index.affx) for mapping genes across organisms and platforms used
in the respective studies.

Comparison with External Data Sets. Mouse MII oocyte transcrip-

tome data were obtained from Su et al. (33), who used custom
designed Affymetrix chips to obtain gene expression profiles of
oocytes and 60 other mouse tissue types. Using their expression
database, we identified 3,617 differentially up-regulated transcripts in the mouse oocyte using the median expression value of
the remaining 60 samples as the baseline (see Data Set 8, which
is available at www.canr.msu.edu兾dept兾ans兾community兾
people兾cibelli㛭jose.html). We selected transcripts with an ex-
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